Presentations

  • AACR Special Conference on Tumor invasion and metastasis, January 20-23, 2013, Sandiego USA
  • 2012 Korean Society for Biochemistry and Molecular Biology (KSBMB) Annual Meeting, May 30-June1, 2012 Seoul, Korea
  • Society of KSBMB for the research of Cancer Microenvironment, Mar 18, 2011, Daejeon Korea
  • Jame Watson Symposium on Cancer, Cold Spring Harbor Conference Asia, April 6-11, 2010, Suzhou China
  • BioProcessing, Biologics & Biotherapeutics 2011, Jul 20- 22, 2011 Edinburgh UK
  • Joint MRS-AACR Conference on Metastasis and the Tumor Microenvironment, Sep 12 -15, 2010 Philadelphia, USA
  • Cancer Microenvironment / 5th International Conference on Tumor Microenvironment: Progression, Therapy, and Prevention, Oct 20-24, 2009 Versailles, France
  • The 5th International Confeence on Tumor Microenvironment: Progression, Therapy and Prevention, October 20-24, 2009, Versilles, France
  • Joint Metastasis Research Society-AACR Conference Metastasis and the Tumor Microenvironment, September 12-15, 2010, Philadelphia, Pennsylvania, United States
  • 21st Meeting of the European Association for Cancer Research, June 26 – 29, 2010, Oslo, Norway
  • AACR 100th Annual Meeting American Association for Cancer Research (AACR), 2009.04.05, Colorado Spring,USA
  • Miami 2008 Nature Symposium, 2008.02,Hawaii
  • Cell Signaling World 2006, Signal Transduction Pathways as therapeutic targets, 25 Jan, 2006, European Conference Center, Kirchberg – Luxembourg
  • AACR 96th Annual Meeting, American Association for Cancer Research (AACR), April 16, 2005,Anaheim,CA,USA
  • AACR 95th Annual Meeting, American Association for Cancer Research (AACR), March 28, 2004, Orange County Convention Center, Orlando, Florida, USA
  • 18th Meeting of the EUROPEAN ASSOCIATION FOR CANCER RESEARCH, European Association for Cancer Research (EACR), 4 July, 2004, Congress Insbruck, Insbruck, Austria
  • New Trands in Functional Proteomics & HUPO Initiatives, Korean Human Proteome Organization (KHUPO), March 25, 2004, Cultural Center, Seoul National University, Seoul, Korea
  • 93th USCAP / 2004. 3.6 Vancouver, BC,Canada
  • 대한 생화학 분자생물학회 / 2003. 7.10 안면도(한국)
  • 대한병리학회 산부인과 병리연구회 연수교육 / 2004. 6.19 삼성서울병원
  • 대한비뇨기종양학회 연수교육 / 2005. 4.2. 고려대학교
  • 대한세포병리학회 15차 학술대회 연수교육 / 2003.11.7 용평 (한국)
  • 대한병리학회 56차 학술대회 / 2004.10.28 제주 (한국)
  • 대한병리학회 55차 학술대회 / 2003.10.31 가톨릭 대학
  • 산부인과 연수교육 / 2005.12.18 삼성 서울병원
  • 대한병리학회57차 추계학술대회 / 2005.10.21 성균관 대학
  • 대한독성학회 연수교육 / 2004.11.5 서울대학교
  • 대한임상병리학회 심포지움 / 2004.11.8 제주도
  • 을지대학 연구소 개원기념 심포지움 / 2004.5.28 대전 을지대학
  • 2회 대한비뇨종양학회 심포지움 / 2004.4.3 고려대학교
  • 대한 전립선 종양학회 심포지움 / 2004.3 충남대학교

Others

Papers  as  a  corresponding author  (Recent 5-yrs) 

Molecular Research 

  • Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J Cell Sci 2010; 123:3507-14
  • In situ identification and localization of IGHA2 in the breast tumor microenvironment by mass spectrometry. J Proteome Res 2012 ;11(9):4567-74.
  • Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling. Breast Cancer Res 2012 ;14(3):R88.
  • Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer. Biochem Biophys Res Commun 2012 ;427(3):642-8.
  • Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer. 2011 ;117(9):1864-73.
  • Molecular portraits of intratumoral heterogeneity in human ovarian cancer. Cancer Lett 2011;307:62-71
  • Proteomic molecular portrait of interface zone in breast cancer. J Proteome Res 2010 9:5638-45
  • Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer. Am J Pathol 2011; 178: 373-81 
  • CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 2010; 29: 2672-80
  • Molecular Proteomics Imaging of Tumor Interfaces by Mass Spectrometry. J Proteome Res 2010; 9:1157-64
  • Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer 2011; 117:1864-73.
  • Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure. J Cell Sci  2007; 120:2284-90
  • HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 2007; 120:1418-25
  • Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells. J Pathol  2007; 212:161-9
  • Induction of Cell Apoptosis in Non-Small Cell Lung Cancer Cells by Cyclin A1 SiRNA. Cancer  Science  2006; 97:1082-92
  • Comparative Proteomics of Ovarian Epithelial Tumors. J Proteome Res 2006;5: 1082-90.
  • Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J Proteome Res  2006 5:643-50
  • Methylation of p16INK4a Is a Non-Rare Event in Cervical Intraepithelial Neoplasia.  Diag Mol Pathol  2006;,15:74-82
  • Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett 2006; 232:170-8.
  • Proteomic Analysis of Progressive Factors in Uterine Cervical Cancer. Proteomics  2005; 5: 1481-93.
  • Loss of cyclin B1 followed by downregulation of cyclin A/cdk2, apoptosis and ati-proliferation in HeLa cell line. Int J Cancer 2005; 116; 520-5.
  • Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix. Clin Cancer Res 2004; 10:1366-74.
  • MMP expression profiling in recurrent stage IB lung cancer. Oncogene 2004;23:845-51
  • Expression of stem cell markers in an uterine endometrium over a lifetime. Fertil Steril 2004;81:403-7

Gynecology

  • Prospective evaluation of longitudinal changes in human papillomavirus genotype and phylogenetic clade associated with cervical disease progression. Gynecol Oncol. 2011;   120:284-90
  • Detection of sexually transmitted infection and human papillomavirus in negative cytology by multiplex-PCR. BMC Infect Dis. 2010; 10:284
  • Glassy cell carcinoma predominantly commits to a squamous lineage and is strongly associated with high-risk type human papillomavirus infection. Int J Gynecol Pathol. 2009 ;28:389-95
  • Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure. J Cell Sci. 2007; 120:2284-94.
  • HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer. 2007; 120:1418-25
  • Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia. Diagn Mol Pathol. 2006; 15:74-82.
  • Multinucleation of koilocytes is actually multilobation. Int J Gynecol Cancer. 2006; 16:686-9.
  • Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett. 2006; 232:170-8
  • Multinucleation of koilocytes is in fact multilobation and is related to aberration of the G2 checkpoint. J Clin Pathol. 2005; 58:576-82
  • Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics. 2005;5:1481-93.
  • G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Gynecol Oncol. 2003; 90:15-22
  • Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer. 2003; 97:1672-80
  • Genotyping of 22 HPV types by DNA chip in Korean women: comparison with cytological diagnosis. Am J Obstet Gynecol 2003; 188:56-62.
  • Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors.Yonsei Med J. 2002; ;43:722-8. Review.
  • Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods. Pathol Res Pract. 1998;194:713-20
  • Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma.Gynecol Oncol. 1998;71:38-45
  • Correlation between G1 cyclins and HPV in the uterine cervix. Int J Gynecol Pathol. 1997 ;16:339-47
  • Effect of cetrorelix acetate on apoptosis and apoptosis regulatory factors in cultured uterine leiomyoma cells. Fertil Steril. 2005; 84:1526-8.

Urology 

  • Composite three-marker assay for early detection of kidney cancer.
    Cancer Epidemiol Biomarkers Prev. 2013;22(3):390-8.
  • Panel of candidate biomarkers for renal cell carcinoma. J Proteome Res. 2010; 9:3710-9.
  • Pathological effects of prostate cancer correlate with neuroendocrine differentiation and PTEN   expression after bicalutamide monotherapy. J Urol 2009;182:1378-84. And 14 articles more